These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25758963)

  • 41. Prostate examination among adult and elderly subjects in southern Brazil: a cross-sectional population-based study.
    Meneghini KFD; Ting HY; Dumith SC
    Sao Paulo Med J; 2020; 138(6):483-489. PubMed ID: 33146243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostate cancer: screening and early detection.
    Tariman JD
    Adv Nurse Pract; 2006 Sep; 14(9):20. PubMed ID: 16972436
    [No Abstract]   [Full Text] [Related]  

  • 43. Prostate-specific antigen testing and prostate cancer screening.
    Djavan B; Eckersberger E; Finkelstein J; Sadri H; Taneja SS; Lepor H
    Prim Care; 2010 Sep; 37(3):441-59, vii. PubMed ID: 20705192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours.
    Jentzmik F; Stephan C; Miller K; Schrader M; Erbersdobler A; Kristiansen G; Lein M; Jung K
    Eur Urol; 2010 Jul; 58(1):12-8; discussion 20-1. PubMed ID: 20117878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defining prostate cancer risk before prostate biopsy.
    Pal RP; Maitra NU; Mellon JK; Khan MA
    Urol Oncol; 2013 Nov; 31(8):1408-18. PubMed ID: 22795499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostate cancer in Jamaica and the wider Caribbean: it is time to consider screening.
    Aiken WD; Eldemire-Shearer D
    West Indian Med J; 2012 Jan; 61(1):90-3. PubMed ID: 22808573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of digital rectal examination and prostate specific antigen in detecting carcinoma prostate.
    Iqbal N; Bhatti AN; Husain S
    J Coll Physicians Surg Pak; 2003 Jun; 13(6):340-2. PubMed ID: 12814533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DRE has vital role in early detection of prostate cancer.
    Rees J
    Practitioner; 2015 Jan; 259(1778):5. PubMed ID: 25726613
    [No Abstract]   [Full Text] [Related]  

  • 49. Prostate cancer detection rate of transrectal ultrasonography, digital rectal examination, and prostate-specific antigen: results of a five-year study of 6- versus 12-core transperineal prostate biopsy.
    Bigliocchi M; Marini M; Nofroni I; Perugia G; Shahabadi H; Ciccariello M
    Minerva Urol Nefrol; 2007 Dec; 59(4):395-402; 403-6. PubMed ID: 17947956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The general practitioner's part in the initiation of diagnostic procedures in prostate cancer].
    Braun KP; May M; Grassmel Y; Führer S; Hoschke B; Braun V
    Aktuelle Urol; 2008 Mar; 39(2):141-6. PubMed ID: 18379968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
    Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate cancer detection by using digital rectal examination: contemporary practice patterns in the United States.
    Tourville EA; Nguyen MM
    Clin Genitourin Cancer; 2013 Sep; 11(3):263-9. PubMed ID: 23647941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Advancement of examination and diagnosis of prostate cancer: General concept].
    Kanehira M; Takata R; Obara W
    Nihon Rinsho; 2016 May; 74 Suppl 3():271-4. PubMed ID: 27344740
    [No Abstract]   [Full Text] [Related]  

  • 54. Screening for prostate cancer--the controversy that refuses to die.
    Barry MJ
    N Engl J Med; 2009 Mar; 360(13):1351-4. PubMed ID: 19297564
    [No Abstract]   [Full Text] [Related]  

  • 55. Methods of early detection of prostate cancer: the role of prostatic specific antigen, transrectal ultrasound and digital rectal examination.
    Pontes JE
    In Vivo; 1994; 8(3):413-4. PubMed ID: 7528556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostate-specific antigen velocity (PSAV): a practical role for PSA?
    Thanigasalam R; Mancuso P; Tsao K; Rashid P
    ANZ J Surg; 2009 Oct; 79(10):703-6. PubMed ID: 19878164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostate-cancer screening.
    Cooperberg MR; Carroll PR
    N Engl J Med; 2009 Jul; 361(2):203; author reply 204-5. PubMed ID: 19593852
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluation of Prostate Cancer Risk Calculators for Shared Decision Making Across Diverse Urology Practices in Michigan.
    Auffenberg GB; Merdan S; Miller DC; Singh K; Stockton BR; Ghani KR; Denton BT
    Urology; 2017 Jun; 104():137-142. PubMed ID: 28237530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis and overdiagnosis of prostate cancer: a personal view.
    Tam PC
    Hong Kong Med J; 2012 Dec; 18(6):456-8. PubMed ID: 23223644
    [No Abstract]   [Full Text] [Related]  

  • 60. The use of nomograms in the detection of prostate cancer.
    Roobol MJ
    Prostate; 2006 Sep; 66(12):1266-7. PubMed ID: 16752374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.